[This review was originally posted at the Nieman Journalism Lab Purchase Lipitor, on March 18, 2011.]

First reactions to The Times' paid-content plans: Yesterday The New York Times rolled out the online paid-content plans they've been talking about for a little more than a year. You get 20 articles a month for free (besides the ones you get to through Google and social media), and after that it's going to cost you anywhere from $15 to $35 per four weeks, depending on what devices you want to access it on. Print subscribers will get it all for free. (Yup, as the Lab's Josh Benton and Forbes' Jeff Bercovici pointed out, that means there are print plans with online access that are cheaper than the online-only ones.) Subscriptions will sold, Lipitor results, among other places, in Apple's iTunes store. Here's The Times' letter to readers and news article, as well as the Lab's glimpse at the paywall and a good paidContent FAQ.

Now for the reaction and analysis: If you only have time for a few pieces, make them Ken Doctor, Steve Outing, and Felix Salmon, Purchase Lipitor. If you want a quick sampler platter of opinions, you can't do any better than the Lab's roundup of 11 experts' thoughts.

There was no consensus of initial opinion about the plan; many supporters spoke up quickly, including The Times' own media critic, David Carr, purchase Lipitor, and The Daily Beast's Howard Kurtz. Poynter newspaper analyst Rick Edmonds broke down the ways it met all the initial criteria of a sound paywall plan, and British j-prof Paul Bradshaw called it "the most mature, intelligent, and commercially sensible paywall model yet," praising its respect for distribution and online engagement. At The Columbia Journalism Review, Lipitor over the counter, Ryan Chittum said it looked good, and Lauren Kirchner issued a rejoinder to the "information wants to be free" crowd. Purchase Lipitor, The Times' detractors were quick to speak up, too. Media analyst Steve Outing laid out most of the basic objections: The prices are too high, people will turn away when they hit the 20-article limit, and the differentiation by device doesn't make sense. (TechCrunch's Erick Schonfeld harped on the latter point, too.) Reuters' Felix Salmon chimed in by saying that the price point is high enough that a lot of regular readers won't subscribe (meaning the plan won't bring in much revenue anyway), and that the Times is discouraging use of its iPad.

At BoingBoing, Lipitor forum, Cory Doctorow said most users will find the metering system frustrating, leading them to find other ways to read The Times or just not read it at all. Techdirt's Mike Masnick made a similar point, adding that The Times isn't adding any value with the plan. That was tech pioneer Dave Winer's main beef: "They're not offering anything to readers other than the Times' survival, and they're not even explicit about that."

Plenty of commentary didn't fall into either the "pro" or "con" camp, of course, Purchase Lipitor. Here at the Lab, Ken Doctor provided the definitive economic analysis of the plan, breaking down the seven tests it must pass to be successful. Discount Lipitor, Then there was the issue of getting around the paywall (or, as Doctor more accurately called it, the fence): Business Insider told us how to do it via Google, and TechCrunch pontificated on the social media loophole that will develop in addition to the current Google one. Media consultant Steve Yelvington downplayed that factor: "It's not supposed to be a bank vault, people. It's a polite request for payment."

Another obvious next question is whether this could be applied to other news organizations. Purchase Lipitor, Meranda Watling of 10,000 Words compared the plan with those of The Wall Street Journal and Newsday, but Amy Gahran of the Knight Digital Media Center gave other newspapers a stern "don't try this at home."

—

Breaking down an old debate at SXSW: Just as they do every March, geeks descended on Austin, Texas, last weekend for the South by Southwest Interactive Festival, and as usual, there was plenty of journalism-related stuff to chew on, even for those of us who didn't attend. The session that seemed to get the most traction online was NYU professor Jay Rosen's psychological analysis of the tension between bloggers and journalists — which is perhaps a bit surprising for a battle that Rosen himself declared "over" six years ago.

Rosen's whole talk is worth a read, online buy Lipitor without a prescription, but here's the gist of it: For journalists, bloggers are the idealized face of all the ideological and professional stresses they deal with, and for bloggers, the conflict helps keep them on the "outside" of the system, allowing them to maintain their innocence and rhetorical power. Snarkmarket's Matt Thompson and Tim Carmody liveblogged their analysis of the talk, and The Guardian summarized it. Lipitor pics, Michele McLellan of the Knight Digital Media Center ripped blogger-hating journalists for fighting an outdated war, but Melissa Bell of the Washington Post called Rosen's characterization of objectivity misleading.

There were plenty of other panels worth reading about, too, including NYU prof Clay Shirky's timely talk on social media and revolution, in which he said that governments routinely overestimate our access to information and underestimate our access to each other, Purchase Lipitor. (The Guardian had a short summary, and Poynter's Julie Moos put together a blow-by-blow in Storify.)

There were also a couple of panels on the value of gaming, particularly in news, as well as sessions on building trust online, using social media to evade censorship, the future of public media, iPad news apps, is Lipitor safe, and SEO tips from Google and Bing. Poynter's Steve Myers pulled together a dozen journalists for an overview of the conference in terms of building community, and an Economist blogger tied this year's SXSW to last year's with a sharp post questioning the story as the basic unit of journalism.

—

A critical eye on NPR's antagonists: The damage to NPR from James O'Keefe's hidden-camera exposé was already done last week, but the scrutiny of the tape itself didn't begin in earnest until the weekend — kicked off by, of all places, Glenn Beck's website, Lipitor from canada,  The Blaze. (Time's James Poniewozik's breakdown is also worth a read.) The site's skepticism of the video's editing was picked up by NPR media reporter David Folkenflik, who examined the issue in a broadcast report. NPR's spokeswoman called the video Purchase Lipitor, "inappropriately edited," but said the executive in the tape had still made "egregious statements."

Whatever O'Keefe's ethics, Poynter's Steve Myers said, there's plenty he understands about today's media environment that we can learn from: Investigative journalism is in demand, raw media communicates "reality," and soundbites and reducing opponents' logic to absurdities trump context in the online media world.

The change in leadership at NPR prompted others to look at the health and direction of the organization overall: The New York Times' David Carr examined NPR's success in light of the public-funding argument, and Poynter's Mallary Jean Tenore laid out the four biggest challenges for NPR's next CEO. The Lab's Nikki Usher looked overseas for public media comparisons, and The Columbia Journalism Review talked to Jonathan Holmes of the Australian Broadcasting Corporation about the public media situation there.

—

A snapshot of the state of journalism: Pew's Project for Excellence in Journalism released its annual State of the Media report this week, summarizing last year as a good one for journalism. The big headline that most media outlets took away from the study was that for the first time, online news consumption has surpassed newspaper use. There were plenty of other nuggets from the study, though, covering a variety of news media.

The study outlined the state of the newspaper industry, touching on all the major themes from circulation to advertising to digital paid-content efforts, Purchase Lipitor. One of the authors of that part of the study, Poynter's Rick Edmonds, Lipitor overnight,  summarized the trends he found interesting.

It also included a look at the economics of startup community journalism, with discussion of nonprofits, ad-based sites, and the Patch model. (Author Michele McLellan summarized her main points here.) The researchers also reported on a survey on mobile news use, and Amy Gahran of the Knight Digital Media Center and Damon Kiesow of Poynter highlighted some of the opportunities for news organizations in its results.

A couple of other tidbits from the study: Search Engine Land's Vanessa Fox focused on revenue from advertising, subscriptions, Lipitor alternatives, and mobile apps, and j-prof Alfred Hermida pointed out the difference between the news agendas of Twitter, blogs and the mainstream media.

—

Twitter tells developers to hold off: Twitter made waves in the tech world late last week when they posted a note Purchase Lipitor, telling developers not to develop any more Twitter clients, saying they'd like to do it themselves, ostensibly for consistency's sake. (Mashable has a great explanation of the issue.) Most of the initial reaction was not enthusiastic: Salon's Dan Gillmor said the note was a reminder that we need other options for our online platforms that aren't controlled by a single company, and Dave Winer said it reinforces the fact the open web is the best place to develop.

Mathew Ingram of GigaOM and developer Fred Oliveira both urged Twitter to rethink its decision, noting that third-party apps like Tweetdeck and Tweetie spurred much of Twitter's initial growth. Lipitor without prescription, And ReadWriteWeb's Marshall Kirkpatrick saw this as a hint at where Twitter is headed culturally: "If you thought Twitter was a place for outlaws, for free thinkers, for innovators - you need to tuck in your shirt, cut your hair and get a clue."

Others, however, defended Twitter: Social media marketer Jesse Stay said he wishes Twitter had done this a while ago, and developer Rob Diana argued that Twitter has finally given developers a solid sense of direction while still giving them some freedom.

—

Reading roundup: A few notes to digest while your bracket goes up in flames:

— The big news story of the past week has been the earthquake, tsunami and their aftermath in Japan, Lipitor online cod. There wasn't a whole lot written about it from a media perspective, but there were a couple of insightful posts, Purchase Lipitor. Doc Searls looked at coverage and concluded that the web is subsuming TV and radio, and Jeff Jarvis asked for separate Twitter hashtags for breaking news event witnesses.

— A few leftover AOL/Huffington Post items: GigaOM's Mathew Ingram looked at why AOL is desperate for some successful content initiatives, Arianna Huffington talked SEO, TechCrunch broke down the journalism/churnalism tension at AOL, and The New York Times' Bill Keller issued a non-apology followup to his Huffington-bashing essay last week.

— A couple of stray items from the commenting discussion of the last couple of weeks: Via O'Reilly Radar, Effects of Lipitor,  statistics showing the integration of Facebook Comments led to fewer comments at TechCrunch, and a defense of anonymous commenting from Paul O'Flaherty.

— Finally, the Lab has the transcript of an interesting talk Northwestern prof Pablo Boczkowski gave about the gap between what news consumers want and what they get, with a thoughtful response from the Lab's Josh Benton. Enjoy.

Similar posts: Diflucan Cost. Diflucan For Sale. Armour Price. Cipro alternatives. Armour blogs. Diflucan duration.
Trackbacks from: Purchase Lipitor. Purchase Lipitor. Purchase Lipitor. Lipitor results. Lipitor street price. Generic Lipitor.

[This review was originally posted at the Nieman Journalism Lab Lipitor Dosage, on April 16, 2010.]

Schmidt and Huffington’s advice for news execs: This week wasn’t a terribly eventful one in the future-of-journalism world, but a decent amount of the interesting stuff that was said came out of Washington D.C., site of the annual American Society of News Editors conference. The most talked-about session there was Sunday night’s keynote address by Google CEO Eric Schmidt, who told the news execs there that their industry is in trouble because it hasn’t found a way to sustain itself financially, not because its way of producing or delivering news is broken. “We have a business-model problem, My Lipitor experience, we don’t have a news problem,” Schmidt said.

After buttering the crowd up a bit, Schmidt urged them to produce news for an environment that’s driven largely by mobile devices, immediacy, and personalization, and he gave them a glimpse of what those priorities look like at Google. Politico and the Lab’s Megan Garber have summaries of the talk, Lipitor canada, mexico, india, and paidContent has video.

There were bunches more sessions and panels (American Journalism Review’s Rem Rieder really liked them), but two I want to highlight in particular. One was a panel with New York Times media critic David Carr, new-media titan Ariana Huffington and the Orlando Sentinel’s Mark Russell on the “24/7 news cycle.” The Lab’s report on the session focused on four themes, Lipitor dangers, with one emerging most prominently — the need for context to make sense out of the modern stream of news. St. Petersburg Times media critic Eric Deggans and University of Maryland student Adam Kerlin also zeroed in on the panelists’ call to develop deeper trust and participation among readers.

The second was a presentation by Allbritton’s Steve Buttry that provides a perfect fleshing-out of the mobile-centric vision Schmidt gave in his keynote, Lipitor Dosage. Poynter’s Damon Kiesow had a short preview, and Buttry has a longer one that includes a good list of practical suggestions for newsrooms to start a mobile transformation. (He also has slides from his talk, and he posted a comprehensive mobile strategy for news orgs back in November, buy Lipitor no prescription, if you want to dive in deep.)

There was plenty of other food for thought, too: Joel Kramer of the Twin Cities nonprofit news org MinnPost shared his experiences with building community, and one “where do we go from here?” panel seemed to capture news execs’ ambivalence about the future of their industry. Students from local universities also put together a blog on the conference with a Twitter stream and short recaps of just about every session, Lipitor brand name, and it’s worth a look-through. Two panels of particular interest: One on government subsidies for news and another with Kelly McBride of Poynter’s thoughts on the “fifth estate” of citizen journalists, bloggers, nonprofits and others.

—

Is a closed iPad bad for news?: In the second week after the iPad’s release, much of the commentary centered once again on Apple’s control over the device. Lipitor Dosage, In a long, thoughtful post, Media watcher Dan Gillmor focused on Apple’s close relationship with The New York Times, posing a couple of arresting questions for news orgs creating iPad apps: Does Apple have the unilateral right to remove your app for any reason it wants, and why are you OK with that kind of control?

On Thursday he got a perfect example, when the Lab’s Laura McGann reported that Pulitzer-winning cartoonist Mark Fiore’s iPhone app was rejected in December because it “contains content that ridicules public figures.” Several other folks echoed Gillmor’s alarm, with pomo blogger Terry Heaton asserting that the iPad is a move by the status quo to retake what it believes is its rightful place in the culture. O’Reilly Radar’s Jim Stogdill says that if you bought an iPad, Lipitor pictures, you aren’t really getting a computer so much as “a 16GB Walmart store shelf that fits on your lap … and Apple got you to pay for the building.” And blogging/RSS/podcasting pioneer Dave Winer says the iPad doesn’t change much for news because it’s so difficult to create media with.

But in a column for The New York Times, web thinker Steven Johnson adds an important caveat: While he’s long been an advocate of open systems, he notes that the iPhone software platform has been the most innovative in the history in computing, despite being closed. Lipitor reviews, He attributes that to simpler use for its consumers, as well as simpler tasks for developers. While Johnson still has serious misgivings about the Apple’s closed policy from a control standpoint, he concludes that “sometimes, if you get the conditions right, a walled garden can turn into a rain forest.”

In related iPad issues, Lipitor price, coupon, DigitalBeat’s Subrahmanyam KVJ takes a step back and looks at control issues with Apple, Facebook, Twitter and Google. Florida j-prof Mindy McAdams has a detailed examination of the future of HTML5 and Flash in light of Adobe’s battle with Adobe over the iPad. Oh yeah, and to the surprise of no one, a bunch of companies, including Google, are developing iPad competitors.

—

News editors’ pessimism: A survey released Monday by the Pew Research Center’s Project for Excellence in Journalism presented a striking glimpse into the minds of America’s news executives, Lipitor Dosage. Lipitor dosage, Perhaps most arresting (and depressing) was the finding that nearly half of the editors surveyed said that without a significant new revenue stream, their news orgs would go under within a decade, and nearly a third gave their org five years or less.

While some editors are looking at putting up paywalls online as that new revenue source, the nation’s news execs aren’t exactly overwhelmed at that prospect: 10 percent are actively working on building paywalls, and 32 percent are considering it. Much higher percentages of execs are working on online advertising, cheap Lipitor, non-news products, local search and niche products as revenue sources.

One form of revenue that most news heads are definitely not crazy about is government subsidy: Three quarters of them, including nearly 90 percent of newspaper editors, had “serious reservations” about that kind of funding (the highest level of concern they could choose). Effects of Lipitor, The numbers were lower for tax subsidies, but even then, only 19 percent said they’d be open to it.

The report itself makes for a pretty fascinating read, and The New York Times has a good summary, too. The St, Lipitor blogs. Pete Times’ Eric Deggans wonders Lipitor Dosage, how bad things would have to get before execs would be willing to accept government subsidies (pretty bad), and the Knight Digital Media Center’s Amy Gahran highlights the statistics on editors’ thoughts on what went wrong in their industry.

—

Twitter rolls out paid search: This week was a big one for Twitter: We finally found out some of the key stats about the microblogging service, including how many users it has (105,779,710), and the U.S. Library of Congress announced it’s archiving all of everyone’s tweets, ever.

But the biggest news was Twitter’s announcement that it will implement what it calls Promoted Tweets — its first major step toward its long-anticipated sustainable revenue plan. As The New York Times explains, Promoted Tweets are paid advertisements that will show up first when you search on Twitter and, Lipitor samples, down the road, as part of your regular stream if they’re contextually relevant. Or, in Search Engine Land’s words, it’s paid search, at least initially.

Search blogger John Battelle has some initial thoughts on the move: He thinks Twitter seems to be going about things the right way, buy no prescription Lipitor online, but the key shift is that this “will mark the first time, ever, that users of the service will see a tweet from someone they have not explicitly decided to follow.” Alex Wilhelm of The Next Web gives us a helpful roadmap of where Twitter’s heading with all of its developments.

—

Anonymity and comments: A quick addendum to last month’s discussion about anonymous comments on news sites (which really has been ongoing since then, just very slowly): The New York Times’ Richard Perez-Pena wrote about many news organizations’ debates over whether to allow anonymous comments, Lipitor class, and The Guardian’s Nigel Willmott explained why his paper’s site will still include anonymous commenting.

Meanwhile, former Salon-er Scott Rosenberg told media companies that they’d better treat it like a valuable conversation if they want it to be one (that means managing and directing it), rather than wondering what the heck’s the problem with those crazy commenters. And here at The Lab, Joshua Benton found that when the blogging empire Gawker made its comments a tiered system, their quality and quantity improved.

—

Reading roundup: This week I have three handy resources, three ideas worth pondering, and one final thought.

Three resources: If you’re looking for a zoomed-out perspective on the last year or two in journalism in transition, Daniel Bachhuber’s “canonical” reading list is a fine place to start. PaidContent has a nifty list of local newspapers that charge for news online, and Twitter went public with Twitter Media, a new blog to help media folks use Twitter to its fullest.

Three ideas worth pondering: Scott Lewis of the nonprofit news org Voice of San Diego talks to the Lab about how “explainers” for concepts and big news stories could be part of their business model, analysts Frederic Filloux and Alan Mutter take a close look at online news audiences and advertising, and Journal Register Co, Lipitor Dosage. head John Paton details his company’s plan to have one newspaper produce one day’s paper with only free web tools. (Jeff Jarvis, an adviser, shows how it might work and why he’s excited.)

One final thought: British j-prof Paul Bradshaw decries the “zero-sum game”attitude by professional journalists toward user-generated content that views any gain for UGC as a loss for the pros. He concludes with a wonderful piece of advice: “If you think the web is useless, make it useful. … Along the way, you might just find that there are hundreds of thousands of people doing exactly the same thing.”

Similar posts: Retin A No Rx. Flagyl No Rx. Armour For Sale. Purchase Cipro online no prescription. Synthroid class. Tramadol pharmacy.
Trackbacks from: Lipitor Dosage. Lipitor Dosage. Lipitor Dosage. Lipitor long term. Lipitor mg. Lipitor used for.